Private equity firm KKR & Co. will buy Envision Healthcare Corp. for $5.57 billion plus debt, after a lengthy sale process by the hospital staffing and surgical center company.
Including debt, the all-cash purchase will value Envision at $9.9 billion, the health-care company said in a statement Monday. Envision said the $46-a-share price represents a 32 percent premium to its stock price in November, when it announced it was reviewing strategic alternatives.
The review kicked off for the Nashville, Tennessee-based company after activist investor Starboard Value, run by Jeff Smith, revealed a stake and said it would make an attractive takeover target. Corvex Management, another activist firm, and shareholder reduced most of its holdings in the first quarter.
In the months after the review started, the physician-services provider was said to draw a parade of interested parties looking at all or part of the company. They included strategic buyers such as UnitedHealth Group Inc., as well as private-equity consortiums comprised of Hellman & Friedman, Onex Corp., and Clayton Dubilier & Rice, and one led by Carlyle Group LP.
KKR is already familiar with Envision. The asset firm’s portfolio company, Air Medical, acquired Envision’s medical transport subsidiary American Medical Response in a $2.4 billion deal announced last year.
Envision shares rose 2.3 percent Monday to $44.65. The company said the KKR deal values Envision at 10.9 times its adjusted earnings before interest, taxes, depreciation, and amortization for the trailing 12 months.
Health services assets have become hot targets for buyers.
Last year, KKR finished raising money for a $1.45 billion health-care fund dedicated to growth stage companies. Health insurance and services giant UnitedHealth has acquired a string of medical practices, and drugstore chain CVS Health Corp. is buying insurer Aetna Inc., with the goal of making CVS’s retail locations hubs for health services. In 2016 Blackstone ended its three-year public-to-private buyout drought with an agreement to buy Team Health Holdings Inc, another health-care staffing company.
“Envision is a leading provider of physician-led services in a health-care system in which physician-patient interactions have a pronounced impact on nearly all health-care decisions,” Jim Momtazee, KKR’s head of health-care investing, said in the statement. “We are excited to partner with the outstanding team.”
J.P. Morgan Securities LLC, Evercore Inc., and Guggenheim Securities LLC served as Envision’s financial advisers, while its legal advisers were Wachtell, Lipton, Rosen & Katz, and Bass, Berry & Sims. KKR’s legal counsel was Simpson Thacher & Bartlett LLP.
Article source: Bloomberg